Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001601830-25-000109

Director acquired 22,016 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dar Zavain · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-18 Grant or award : show line 1 in the form +22,016 132,893 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-18 Grant or award : show line 2 in the form Stock Option (Right to Buy) +44,031 44,031 D
Loading xslF345X05/wk-form4_1750713786.xml…